Biology of Hepatitis-C Virus
Dr. Sohail A. Qureshi
Hepatitis-C viral (HCV) infections reduce the quality of life for over 170 million people worldwide. Although HCV was discovered about 21 years ago, the available treatment options for infected individuals are limited. Despite much effort, development of vaccines and drugs against HCV has been hampered due to rapid evolution of the virus. Our group is interested in studying the basic biology of HCV and in particular to understand how HCV encoded proteins influence the transcriptome, proteome and epigenome of infected hepatocytes during the different stages of infection. Additionally, our aim is to identify conserved regions within the HCV genome that may serve as useful vaccine candidates.
- Qureshi, S.A. , Hepatitis-C Therapy: The Future Looks Bright European Journal of Medical Microbiology & Infectious Diseases 28: 1409-1413